MedElevator Войти в исследования
← Поиск публикаций
Медицинская библиотека · The Journal of clinical and aesthetic dermatology · 2026

The Impact of Dupilumab on Psychological Wellbeing in Moderate-to-Severe Atopic Dermatitis Patients: A Phase IV Clinical Trial.

Johnson Chandler E, Elhage Kareem G, Spencer Riley K, Jin Joy Q, Yeroushalmi Samuel, Davis Mitchell S, Hakimi Marwa, Liao Wilson, Bhutani Tina

СтатьяПеревод пока не подготовлен

Аннотация

OBJECTIVE

This study aims to prospectively evaluate the emotional impact of dupliumab treatment on patients with atopic dermatitis (AD) using a validated psychometric instrument, the Psychological General Wellbeing (PGWB) index. This index is widely used in nondermatologic conditions and assesses self-representations of intrapersonal affective and emotional states reflecting a sense of subjective wellbeing or distress.

METHODS

This was a Phase IV, open-label clinical trial using dupilumab for the treatment of moderate-to-severe AD. The primary endpoint was the change in PGWB score at Week 16 of dupilumab treatment compared to baseline.

RESULTS

A total of 24 participants completed the study. The change in average PGWB score after 16 weeks of treatment with dupilumab compared to baseline was not statistically significant (5.8±19.7; P=0.15). There was significant improvement in PGWB score at Week 52 of treatment (8.5±17.4; P=0.03). Mean Eczema Area and Severity Index (EASI) improvements at Weeks 16 and 52 were 60.3% and 76.8%, respectively. Regarding Investigator Global Assessment (IGA), 29.2% and 41.7% of participants achieved a score of 0 or 1 at Weeks 16 and 52, respectively.

LIMITATIONS: This study did not have a control arm and was limited by small sample size.

CONCLUSION

Treatment with dupilumab for 52 weeks was associated with improvement of psychological wellbeing, suggesting that intervention with this interleukin (IL) 4/IL-13 inhibitor is capable of restoring quality of life in these patients.

TRIAL ADMINISTRATION: NCT03667014.

Для цитирования: Johnson Chandler E, Elhage Kareem G, Spencer Riley K, Jin Joy Q, Yeroushalmi Samuel, Davis Mitchell S, Hakimi Marwa, Liao Wilson, Bhutani Tina. The Impact of Dupilumab on Psychological Wellbeing in Moderate-to-Severe Atopic Dermatitis Patients: A Phase IV Clinical Trial.. The Journal of clinical and aesthetic dermatology. 2026.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.